DIATHEVA launches for the first time PBRT 2.0 Antimicrobial Resistance, News DIATHEVA launches for the first time PBRT 2.0zancan2021-01-27T16:56:24+01:00July 5th, 2017|Read More
Diatheva coordinates: PrInT-Age “Un approccio integrato per la promozione della salute degli anziani e delle persone fragili: prevenzione delle infezioni, integrazione nutrizionale e terapie personalizzate” News Diatheva coordinates: PrInT-Age “Un approccio integrato per la promozione della salute degli anziani e delle persone fragili: prevenzione delle infezioni, integrazione nutrizionale e terapie personalizzate”zancan2021-02-09T14:47:29+01:00April 10th, 2017|Read More
BIO 2016 : DIATHEVA presents “scFv 2G8” monoclonal antibody a new approach to fungal infections Clinical Diagnostics, Life Sciences, News BIO 2016 : DIATHEVA presents “scFv 2G8” monoclonal antibody a new approach to fungal infectionszancan2021-01-27T16:56:35+01:00June 9th, 2016|Read More
New pubblication Diatheva’s pipeline antibody therapeutics Clinical Diagnostics, Life Sciences, News New pubblication Diatheva’s pipeline antibody therapeuticszancan2021-01-27T16:56:40+01:00January 13th, 2016|Read More
The new Italian guideline for the prevention and control of Legionellosis were approved Environment, News The new Italian guideline for the prevention and control of Legionellosis were approvedzancan2021-01-27T16:56:47+01:00June 9th, 2015|Read More
Detection and quantification of Legionella spp Environment, News Detection and quantification of Legionella sppzancan2021-01-27T16:56:52+01:00March 9th, 2015|Read More
DIATHEVA , partner in the co-development of a recombinant antibody for the treatment of Ewing Sarcoma Clinical Diagnostics, Life Sciences, News DIATHEVA , partner in the co-development of a recombinant antibody for the treatment of Ewing Sarcomazancan2021-01-27T16:56:57+01:00February 13th, 2015|Read More
